Universal Health International Group Holding Ltd operates within the Drug stores and proprietary stores sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Universal Health International Group Holding Ltd with three other
drug stores in Asia:
Sapporo Drug Store Co., Ltd.
sales of 62.77 billion Japanese Yen [US$561.76 million]
Yifeng Pharmacy Chain Co Ltd
(3.73 billion Chinese Renmimbi [US$539.64 million]
of which 94%
was Medicine Retail), and
Vimedimex Medi Pharma JSC
based in Vietnam
(12.99 trillion Dong [US$557.37 million]
During the year ended December of 2016, sales at
Universal Health International Group Holding Ltd were HK$3.94 billion (US$503.05 million).
decrease of 33.5%
versus 2015, when the company's sales were HK$5.92 billion.
Contributing to the drop in overall sales was the 53.2% decline
in Distributions, from HK$4.29 billion to HK$2.01 billion.
There were also decreases in sales in
Retails I (down 34.7% to HK$1.63 billion)
Retails Ii (down 30.0% to HK$302.68 million)